The senior scientist at Eterna Therapeutics discussed the company’s numerous presentations at ASGCT’s 2023 conference.
Kyle Garland, PhD
Advertisement
Articles by Kyle Garland, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Rabi Hanna, MD, on Evaluating Gene Editing Therapy Reni-Cel for Severe Sickle Cell Disease
2
Hematology-Oncology Immunotherapy Highlights at ASH 2025
3
Assessing FDA-Approved CAR-T in Patients With Multiple Myeloma and Renal Failure
4
Deevyashali Parekh, MBBS, on Evaluating CAR-T in Patients With Multiple Myeloma and Renal Failure
5
